316 related articles for article (PubMed ID: 3981060)
21. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study.
Hofmann AF; Grundy SM; Lachin JM; Lan SP; Baum RA; Hanson RF; Hersh T; Hightower NC; Marks JW; Mekhjian H; Shaefer RA; Soloway RD; Thistle JL; Thomas FB; Tyor MP
Gastroenterology; 1982 Oct; 83(4):738-52. PubMed ID: 7106505
[TBL] [Abstract][Full Text] [Related]
22. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment.
Ichimiya H; Egestad B; Nazer H; Baginski ES; Clayton PT; Sjövall J
J Lipid Res; 1991 May; 32(5):829-41. PubMed ID: 2072042
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
Bateson MC; Ross PE; Murison J; Bouchier IA
Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
[TBL] [Abstract][Full Text] [Related]
24. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
25. [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)].
Fromm H; Erbler HC; Eschler A; Schmidt FW
Klin Wochenschr; 1976 Dec; 54(23):1125-31. PubMed ID: 1003870
[TBL] [Abstract][Full Text] [Related]
26. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
[TBL] [Abstract][Full Text] [Related]
27. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG
Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
[TBL] [Abstract][Full Text] [Related]
28. Human cecal bile acids: concentration and spectrum.
Hamilton JP; Xie G; Raufman JP; Hogan S; Griffin TL; Packard CA; Chatfield DA; Hagey LR; Steinbach JH; Hofmann AF
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G256-63. PubMed ID: 17412828
[TBL] [Abstract][Full Text] [Related]
29. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
Tint GS; Bullock J; Batta AK; Shefer S; Salen G
Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
[TBL] [Abstract][Full Text] [Related]
30. Fecal and biliary bile acid composition after partial ileal bypass operation.
Koivisto PV
Digestion; 1988; 39(1):52-60. PubMed ID: 3396774
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of biliary cile acids in rat: electron impact and ammonia chemical ionization mass spectrometric analyses of bile acids.
Kuriyama K; Ban Y; Nakashima T; Murata T
Steroids; 1979; 34(6 Spec no):717-28. PubMed ID: 538777
[TBL] [Abstract][Full Text] [Related]
32. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
33. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
34. Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.
James O; Cullen J; Bouchier IA
Q J Med; 1975 Apr; 44(174):349-67. PubMed ID: 1178813
[TBL] [Abstract][Full Text] [Related]
35. [The significance of the bacterial steroid degradation for the etiology of large bowel cancer. VIII. Transformation of cholic-, chenodeoxycholic-, and deoxycholic acid by lecithinase-lipase-negative clostridia].
Edenharder R; Deser HJ
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):91-104. PubMed ID: 7324622
[TBL] [Abstract][Full Text] [Related]
36. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
[TBL] [Abstract][Full Text] [Related]
37. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)].
Hrabák P; Dosková M; Soucková E
Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002
[No Abstract] [Full Text] [Related]
38. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
39. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
Iser JH; Murphy GM; Dowling RH
Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
[No Abstract] [Full Text] [Related]
40. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.
Attili AF; Angelico M; Cantafora A; Alvaro D; Capocaccia L
Med Hypotheses; 1986 Jan; 19(1):57-69. PubMed ID: 2871479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
